Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases. Through cutting-edge science across multiple modalities, Vertex has approved medicines that treat the underlying causes of multiple diseases and conditions and has a broad and deep clinical pipeline.
Vertex received U.S. Food and Drug Administration (FDA) approval in January 2025 for a medication for the treatment of moderate-to-severe acute pain in adults. This marks a significant milestone as it represents the first class of therapy approved for patients with moderate-to-severe acute pain in over 20 years.
Click to learn more.